These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30868702)

  • 1. Perceptions about oral isotretinoin treatment.
    Tugrul Ayanoglu B; Demirdag HG; Yalici Armagan B; Bezirgan O
    Dermatol Ther; 2019 May; 32(3):e12873. PubMed ID: 30868702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.
    Zainab Z; Malik NA; Obaid S; Malik S; Aftab K; Mumtaz M; Pervez A; Syed Z
    J Ayub Med Coll Abbottabad; 2021; 33(1):60-63. PubMed ID: 33774956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Perspectives: Treating acne with isotretinoin.
    Pediatr Dermatol; 2015; 32(6):e324-5. PubMed ID: 26584707
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of acne with oral isotretinoin in patients with cystic fibrosis.
    Perera E; Massie J; Phillips RJ
    Arch Dis Child; 2009 Aug; 94(8):583-6. PubMed ID: 19465582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients.
    Cannizzaro MV; Dattola A; Garofalo V; Del Duca E; Bianchi L
    G Ital Dermatol Venereol; 2018 Apr; 153(2):161-164. PubMed ID: 29564872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
    Verros CD; Rallis E
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
    [No Abstract]   [Full Text] [Related]  

  • 8. Knowledge levels and concerns about oral isotretinoin treatment in the parents of adolescent acne patients.
    Kara Polat A; Akin Belli A; Ergun EZ; Manav Bas V; Erdil D; Koku Aksu AE; Gurel MS
    Dermatol Ther; 2020 Jul; 33(4):e13669. PubMed ID: 32459383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?
    Yıldızgören MT; Rifaioğlu EN; Demirkapı M; Ekiz T; Micooğulları A; Şen T; Turhanoğlu AD
    Cutis; 2015 Jul; 96(1):33-6. PubMed ID: 26244352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
    Rademaker M
    Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YouTube as a source of dermatologic information on isotretinoin.
    Xiang L; Ravichandran S; Tamashunas N; Wan A; Mazmudar RS; Scott JF
    J Am Acad Dermatol; 2020 Aug; 83(2):653-655. PubMed ID: 31843656
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and adverse events of oral isotretinoin for acne: a systematic review.
    Vallerand IA; Lewinson RT; Farris MS; Sibley CD; Ramien ML; Bulloch AGM; Patten SB
    Br J Dermatol; 2018 Jan; 178(1):76-85. PubMed ID: 28542914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin.
    Brito Mde F; Sant'Anna IP; Galindo JC; Rosendo LH; Santos JB
    An Bras Dermatol; 2010; 85(3):331-7. PubMed ID: 20676466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dietary supplement to reduce side effects of oral isotretinoin therapy in acne patients.
    Fabbrocini G; Cameli N; Lorenzi S; De Padova MP; Marasca C; Izzo R; Monfrecola G
    G Ital Dermatol Venereol; 2014 Aug; 149(4):441-5. PubMed ID: 25068233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public Understanding and Awareness of Isotretinoin Use and Safety in Al Ahsa, Eastern Saudi Arabia.
    Younis NS; Al-Harbi NY
    Ther Innov Regul Sci; 2019 Sep; 53(5):618-622. PubMed ID: 30380941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal hematuria associated with oral isotretinoin treatment in a patient with acne vulgaris.
    Sarifakioglu E; Yilmaz AE; Erpolat S
    Pediatr Dermatol; 2012; 29(5):668-9. PubMed ID: 22067016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational retrospective study evaluating the effects of oral isotretinoin in keloids and hypertrophic scars.
    Guadanhim LR; Gonçalves RG; Bagatin E
    Int J Dermatol; 2016 Nov; 55(11):1255-1258. PubMed ID: 27419807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
    Baykal Selçuk L; Aksu Arıca D; Baykal Şahin H; Yaylı S; Bahadır S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):176-179. PubMed ID: 27764978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.